What are the indications for endoscopic retrograde cholangiopancreatography (ERCP) in patients with acute pancreatitis?

ERCP Indications in Acute Pancreatitis

ERCP is indicated in acute pancreatitis primarily for two clear-cut scenarios: (1) acute cholangitis complicating gallstone pancreatitis (immediate ERCP required), and (2) common bile duct obstruction in gallstone pancreatitis (ERCP within 24-72 hours). Routine ERCP for all cases of acute pancreatitis, even severe gallstone pancreatitis without cholangitis or obstruction, is not recommended 1.

Primary Indications (Grade A Evidence)

Immediate/Urgent ERCP (Within 24 Hours)

• Acute cholangitis with gallstone pancreatitis - This is the strongest indication, with evidence showing reduced mortality and complications 1, 2
  • Clinical signs: fever, rigors, positive blood cultures
  • Laboratory: progressively worsening liver function tests
  • This represents a Grade 1B recommendation with clear mortality benefit

Early ERCP (Within 24-72 Hours)

• Common bile duct obstruction without cholangitis - Grade 2B recommendation 1
  • Evidence shows reduction in local complications
  • Timing within 72 hours is acceptable; urgent (<24h) offers no additional benefit over early (24-72h) 3

Controversial/Not Recommended Scenarios

Severe Gallstone Pancreatitis Without Obstruction or Cholangitis

Do not perform routine ERCP - The evidence here has evolved significantly. While older 1998 UK guidelines suggested ERCP for severe gallstone pancreatitis failing to improve within 48 hours 4, the more recent and higher-quality 2019 WSES guidelines explicitly state this "cannot be recommended" (Grade 2B) 1. The 2018 AGA guidelines similarly recommend against routine urgent ERCP in acute biliary pancreatitis without cholangitis 2.

The key distinction: systematic reviews of seven RCTs found no mortality benefit for routine ERCP in predicted severe acute gallstone pancreatitis when cholangitis and obstruction are absent 1.

Mild Gallstone Pancreatitis

Routine preoperative ERCP is not indicated unless specific features suggest CBD stones 4:

• Jaundice
• Persistently elevated liver function tests
• Dilated CBD on ultrasound

Without these features, proceed directly to cholecystectomy with intraoperative cholangiography rather than preoperative ERCP, given the inherent procedural risks 4.

Algorithmic Approach

Step 1: Identify gallstone etiology

• If non-biliary pancreatitis → ERCP not indicated

Step 2: Assess for cholangitis

• Fever + rigors + positive blood cultures + worsening LFTs → Immediate ERCP (within 24h)

Step 3: If no cholangitis, assess for CBD obstruction

• Persistent jaundice, elevated bilirubin, dilated CBD on imaging → Early ERCP (within 24-72h)

Step 4: If severe pancreatitis without cholangitis/obstruction

• No ERCP - manage conservatively, reassess if clinical deterioration

Step 5: For mild gallstone pancreatitis

• No routine ERCP unless high suspicion for CBD stones (see criteria above)
• Proceed to cholecystectomy within 2-4 weeks with intraoperative assessment

Critical Caveats

• Always perform ERCP under antibiotic cover 4
• ERCP carries inherent risks (6.1% morbidity in real-world practice) that must be weighed against benefits 5
• The evidence base has shifted: prioritize 2019 WSES 1 and 2018 AGA 2 guidelines over older 1998 recommendations, as more recent high-quality RCTs show no benefit for routine ERCP in severe disease without specific indications
• Real-world practice often shows poor guideline adherence, with only 25.9% of ERCPs performed within appropriate timeframes 5